Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008 Dec;15(10):993-1001.
doi: 10.1177/1933719108324132.

The expression and ovarian steroid regulation of endometrial micro-RNAs

Affiliations
Comparative Study

The expression and ovarian steroid regulation of endometrial micro-RNAs

Tannaz Toloubeydokhti et al. Reprod Sci. 2008 Dec.

Retraction in

  • Retraction.
    [No authors listed] [No authors listed] Reprod Sci. 2014 Oct;21(10):1326. doi: 10.1177/1933719114547496. Epub 2014 Aug 26. Reprod Sci. 2014. PMID: 25161172 Free PMC article. No abstract available.

Abstract

MicroRNAs (miRNAs) which regulate gene expression stability displayed an aberrant expression profile in ectopic endometrium (ECE) as compared to eutopic (EUE) and normal endometrium (NE). We assessed the expression of miR-17-5p, miR-23a, miR-23b and miR-542-3p, their predicted target genes, steroidogenic acute regulatory protein, aromatase and cyclooxygenase-2, and influence of ovarian steroids on their expression in endometrial stromal (ESC) and glandular epithelial cells (GEC). The results indicated a lower expression of miR-23b and miR-542-3p and higher level of miR-17-5p in paired ECE and EUE as compared with NE. These levels were elevated and inversely correlated with the level of expression of their respective target genes in ECE. The expression of these miRNAs and genes was differentially regulated by 17beta- estradiol, medroxyprogesterone acetate, ICI-182780 and RU-486, or their respective combinations in ESC and GEC. We concluded that altered expression of specific miRNAs in ECE, affecting the stability of their target genes expression, has direct implications in pathogenesis of endometriosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Bar graphs show the mean ± SEM of relative expression of miR-23a, miR-23b, miR-17-5p, and miR-542-3p as well as CYP19A1, steroidogenic acute regulatory protein (StAR), and cyclooxygenase 2 (COX-2) in the endometrium of women without endometriosis (EN) and paired eutopic (Eutopic Endo, EU) and ectopic (Ectopic-Endo, EC) endometrium. The level of expression of these micro-RNAs (miRNAs) and messenger ribonucleic acids (mRNAs) was determined relative to control using ΔΔCT method and their mean values in EN were independently set at 1. Asterisks ** and *** are significantly different from *, and ** are different from *** (P < .05) analyzed using either a 2-tailed Student t test for 2 group comparisons or AN OVA with Tukey’s test for multiple comparisons.
Figure 2
Figure 2
Bar graphs show the expression of miR-17-5p, miR-23a, miR-23b, and miR-542-3p as well as steroidogenic acute regulatory protein (StAR), cyclooxygenase 2 (COX-2), and CYP19A1 in endometrial stromal cells (ESCs) isolated from women without endometriosis and the effect of ovarian steroids on their expression. The ESCs (1 × 106/well in 6-well plates) were cultured and following treatments with 17β-estradiol (E2), ICI-182780 (ICI), E2 + ICI, medroxyprogesterone acetate (MPA), RU-486 (RU), and MPA + RU, their total RNA was isolated and subjected to real-time polymerase chain reaction (PCR). The data were expressed as relative to control using ΔΔCT method and following independent normalization the expression level of each micro-RNA (miRNA) and messenger RNA (mRNA) in untreated control (Crtl) was arbitrarily set as 1. Asterisk * is significantly different from Ctrl, with arrows showing the differences between corresponding treatment groups, ie, E2, ICI, E2 + ICI. These experiments were preformed using 3 independent cell cultures and results were analyzed using either a 2-tailed Student t test for 2 group comparisons or ANOVA with Tukey’s test for multiple comparisons with P < .05 was considered significant.
Figure 3
Figure 3
Bar graphs show the expression of miR-17-5p, miR-23a, miR-23b, and miR-542-3p as well as steroidogenic acute regulatory protein (StAR), cyclooxygenase 2 (COX-2) and CYP19A1 in endometrial glandular epithelial cells (GEC) isolated from women without endometriosis and the effect of ovarian steroids on their expression. The endometrial stromal cells (ESCs; 1 × 106/well in 6-well plates) were cultured and following treatments with 17β-estradiol (E2), ICI-182780 (ICI), E2 + ICI, medroxyprogesterone acetate (MPA), RU-486 (RU) and MPA + RU, their total RNA was isolated and subjected to real-time polymerase chain reaction (PCR). The data were expressed as relative to control using ΔΔCT method and following independent normalization, the expression level of each micro-RNA (miRNA) and messenger RNA (mRNA) in untreated control (Crtl) was arbitrarily set as 1. Asterisk * is significantly different from Ctrl, with arrows showing the differences between corresponding treatment groups, ie, E2, ICI, E2 + ICI. These experiments were preformed using 3 independent cell cultures and the results were analyzed using either a 2-tailed Student t test for 2 group comparisons or ANOVA with Tukey’s test for multiple comparisons with P < .05 considered significant.

Comment in

  • Findings of Research Misconduct.
    [No authors listed] [No authors listed] Fed Regist. 2017 Aug 3;82(148):36150-36151. Fed Regist. 2017. PMID: 28857091 Free PMC article. No abstract available.

Similar articles

Cited by

References

    1. Pan Q, Luo X, Toloubeydokhti T, Chegini N. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod. 2007;13:797–806. - PubMed
    1. Matsuzaki S, Fukaya T, Uehara S, Murakami T, Sasano H, Yajima A. Characterization of messenger RNA expression of estrogen receptor-alpha and -beta in patients with ovarian endometriosis. Fertil Steril. 2000;73:1219–1225. - PubMed
    1. Matsuzaki S, Murakami T, Uehara S, Canis M, Sasano H, Okamura K. Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis. Fertil Steril. 2001;75:1198–1205. - PubMed
    1. Bulun SE, Cheng YH, Yin P, et al. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol. 2006;248:94–103. - PubMed
    1. Attar E, Bulun SE. Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Update. 2006;12:49–56. - PubMed

Publication types